Dual Therapy Offers Both Benefit and Risk After Common Type of Cardiac [1]
A new analysis by a team led by Dr. Mario Gaudino of Weill Cornell Medicine and NewYork-Presbyterian shows that a combination of two antiplatelets drugs can benefit patients after coronary artery bypass graft surgery but also increases the risk of potentially dangerous bleeding. Reported on August 9 in JAMA, the finding suggests physicians should carefully weigh the use of these medications after this procedure.
Source name:
News Medical
Resource link:
Subspecialty(ies):
Cardiac [5]